OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Ana Dillen, Indy Bui, Megan Jung, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1237-1237
Open Access | Times Cited: 8
Ana Dillen, Indy Bui, Megan Jung, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1237-1237
Open Access | Times Cited: 8
Showing 8 citing articles:
EZH2 regulatory roles in cancer immunity and immunotherapy
Keywan Mortezaee
Pathology - Research and Practice (2025) Vol. 270, pp. 155992-155992
Closed Access | Times Cited: 1
Keywan Mortezaee
Pathology - Research and Practice (2025) Vol. 270, pp. 155992-155992
Closed Access | Times Cited: 1
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response
Shantanu Gupta, Daner A. Silveira, P Lorenzoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8264-8264
Open Access | Times Cited: 6
Shantanu Gupta, Daner A. Silveira, P Lorenzoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8264-8264
Open Access | Times Cited: 6
Bioinformatics Analysis of the Expression and Prognostic Significance of Transcription Factor YY1 in Gastric Cancer
W H Chen, Huanhuan Wang, Ntiak Achi, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access
W H Chen, Huanhuan Wang, Ntiak Achi, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access
Parabacteroides distasonis promotes CXCL9 secretion of tumor-associated macrophages and enhances CD8+T cell activity to trigger anti-tumor immunity against anti-PD-1 treatment in non-small cell lung cancer mice
Zhijun Fan, Yi Zheng, Sheng Li, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
Zhijun Fan, Yi Zheng, Sheng Li, et al.
BMC Biotechnology (2025) Vol. 25, Iss. 1
Open Access
The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications
Adam Merenstein, Loiy Obeidat, Apostolos Zaravinos, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 19-19
Open Access | Times Cited: 2
Adam Merenstein, Loiy Obeidat, Apostolos Zaravinos, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 19-19
Open Access | Times Cited: 2
Therapeutic Implications of Targeting YY1 in Glioblastoma
Inesa Navasardyan, Apostolos Zaravinos, Benjamin Bonavida
Cancers (2024) Vol. 16, Iss. 11, pp. 2074-2074
Open Access
Inesa Navasardyan, Apostolos Zaravinos, Benjamin Bonavida
Cancers (2024) Vol. 16, Iss. 11, pp. 2074-2074
Open Access
YY1 downregulation underlies therapeutic response to molecular targeted agents
Shichao Zhou, Jingyu Zang, Mei‐Chun Cai, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Shichao Zhou, Jingyu Zang, Mei‐Chun Cai, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access
Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access
